Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination

Journal of Asthma

Volumn 48, Issue 6, 2011, Pages 625-631

  Laforce, Craig ^a   Weinstein, Cindy ^b   Nathan, Robert A ^c   Weinstein, Steven F ^d   Staudinger, Heribert ^b   Meltzer, Eli O ^e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Asthma and Allergy Associates and Research Center   (United States)

^d Allergy and Asthma Specialists Medical Group   (United States)

^e ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

Author keywords

Dose counter; Dulera; Inhaler; Mometasone furoate formoterol; Satisfaction

Indexed keywords

FORMOTEROL FUMARATE PLUS MOMETASONE FUROATE;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; ERGONOMICS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MILD PERSISTENT ASTHMA; MULTICENTER STUDY; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; CHILD; COMPREHENSION; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMAN ENGINEERING; HUMANS; MALE; METERED DOSE INHALERS; MIDDLE AGED; PATIENT SATISFACTION; PREGNADIENEDIOLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; YOUNG ADULT;

EID: 79960483231     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.587579     Document Type: Article

References (26)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2006. Available at: http://www.goldcopd.com/Guidelineitem. asp?l1=2&l2=1&intId=989. Accessed August 1, 2007.
2. National Asthma Education and Prevention Program. Expert panel report 3: Guidelines for the diagnosis and management of asthma. Full Report 2007. Available at: http://www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.htm. Accessed January 12, 2010.
3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention, 2010. National Heart, Lung, and Blood Institute. Available at: http://www.ginasthma.org/. Accessed February 24, 2010.
4. Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Engl J Med 1986; 315:870-874. (Pubitemid 16028483)
5. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, Guyatt G. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127:335-371. (Pubitemid 41724594)
6. Anderson P. Patient preference for and satisfaction with inhaler devices. Eur Respir Rev 2005; 14:109-116. (Pubitemid 43028768)
7. Wasserman RL, Sheth K, Lincourt WR, Locantore NW, Rosenzweig JC, Crim C. Real-world assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc 2006; 27: 486-492. (Pubitemid 44916014)
8. Welch MJ, Nelson HS, Shapiro G, Bensch GW, Sokol WN, Smith JA, Parasuraman BM. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med 2004; 17:129-139. (Pubitemid 38955673)
9. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004; 114:1288-1293. (Pubitemid 39575880)
10. Weinstein C, Staudinger H, Scott I, Amar NJ, Laforce C. Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. Respir Med 2011; 105:979-988.
11. Sheth K, Wasserman RL, Lincourt WR, Locantore NW, Carranza- Rosenzweig J, Crim C. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: performance and patient satisfaction. Int J Clin Pract 2006; 60: 1218-1224. (Pubitemid 44363657)
12. Crim C, Lincourt WR, Locantore N, Carranza Rosenzweig JR Handling performance and patient satisfaction of a metered-dose inhaler with integrated dose counter for patients with COPD. Chest Meeting Abstracts, Oct 2005; 128: 258S.
13. Morice A, Stradling J, Barnes N. Assessment of the acceptability of a new salbutamol multidose dry powder inhaler (DPI) in patients with asthma. Clin Drug Investig 2000; 19:195-199. (Pubitemid 30166912)
14. Sander N, Fusco-Walker SJ, Chipps B. MDIS: can you count on them? Ann Allergy Asthma Immunol 2004; 92:147.
15. Sander N, Fusco-Walker SJ, Harder JM, Chipps BE. Dose counting and the use of pressurized metered-dose inhalers: running on empty. Ann Allergy Asthma Immunol 2006; 97:34-38. (Pubitemid 44156334)
16. Shah S, White M, Uryniak T, O'Brien CD. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. Allergy Asthma Proc 2010; 31:40-48.
17. Moore AC, Stone S. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler. Int J Clin Pract 2004; 58:444-450. (Pubitemid 38786564)
18. Rickenbach MA, Julious SA. Assessing fullness of asthma patients' aerosol inhalers. Br J Gen Pract 1994; 44:317-318. (Pubitemid 24224583)
19. Rubin BK, Durotoye L. How do patients determine that their metereddose inhaler is empty? Chest 2004; 126:1134-1137. (Pubitemid 39391242)
20. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000; 94:496-500. (Pubitemid 30353008)
21. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009; 64:939-943.
22. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50:1360-1374; discussion 1374-1375. (Pubitemid 46173323)
23. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J 2002; 19: 246-251. (Pubitemid 34162824)
24. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102:593-604.
25. Prabhakaran L, Lim G, Abisheganaden J, Chee CB, Choo YM. Impact of an asthma education programme on patients' knowledge, inhaler technique and compliance to treatment. Singapore Med J 2006; 47:225-231. (Pubitemid 43384838)
26. Broeders ME,Molema J, Hop WC, Folgering HT. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003; 16:131-141. (Pubitemid 36702667)